CC
OMIC

Cannell Capital’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Cannell Capital’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-475
Closed -$17.2K – 92
2023
Q1 		$17.2K Hold
475
– – ﹤0.01% 87
2022
Q4 		$28.6K Hold
475
– – 0.01% 83
2022
Q3 		$36K Buy
475
+375
+375% +$39.2K 0.01% 84
2022
Q2 		$12K Buy
+100
New +$11.7K ﹤0.01% 71

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cannell Capital's OMIC Position: Q2 2023 in Review

Cannell Capital sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 475 shares — an estimated $17.2K sold.

Cannell Capital first reported a position in OMIC in Q2 2022 and held it in 4 quarters. The position peaked at $36K in Q3 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Cannell Capital reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cannell Capital sold 475 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $17.2K.
  • Cannell Capital first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Cannell Capital's Singular Genomics Systems, Inc. Common Stock position peaked at $36K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Cannell Capital's 13F filing for Q2 2023, filed 14 Aug 2023.